Differential relationships of reactive astrocytes and microglia to fibrillar amyloid deposits in alzheimer disease

Journal of Neuropathology and Experimental Neurology

Volumn 72, Issue 6, 2013, Pages 462-471

  Serrano Pozo, Alberto ^a   Muzikansky, Alona ^a   Gómez Isla, Teresa ^a   Growdon, John H ^a   Betensky, Rebecca A ^a,b   Frosch, Matthew P ^a   Hyman, Bradley T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Alzheimer disease; Amyloid plaques; Apolipoprotein E; Astrocytes; Microglia

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; DIRECT YELLOW 7; THIOFLAVINE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; FEMALE; GENOTYPE; GLIA CELL; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MICROGLIA; NEOCORTEX; PRIORITY JOURNAL; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ASTROCYTES; BRAIN; FEMALE; HUMANS; MALE; MICROGLIA; PLAQUE, AMYLOID;

EID: 84878655531     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0b013e3182933788     Document Type: Article

References (64)

1. Masliah E, Mallory M, Hansen L, et al. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci Lett 1994;174:67-72
2. Su JH, Cummings BJ, Cotman CW. Plaque biogenesis in brain aging and Alzheimer's disease. I. Progressive changes in phosphorylation states of paired helical filaments and neurofilaments. Brain Res 1996;739: 79-87
3. Su JH, Cummings BJ, Cotman CW. Plaque biogenesis in brain aging and Alzheimer's disease. II. Progressive transformation and developmental sequence of dystrophic neurites. Acta Neuropathol 1998;96: 463-71
4. Dickson TC, Vickers JC. The morphological phenotype of amyloid-beta deposits and associated neuritic change in Alzheimer's disease. Neuroscience 2001;105:99-107
5. Itagaki S, McGeer PL, Akiyama H, et al. Relationship of microglia and astrocytes to amyloid deposits of Alzheimer disease. J Neuroimmunol 1989;24:173-82
6. Wisniewski HM, Wegiel J. Spatial relationships between astrocytes and classical plaque components. Neurobiol Aging 1991;12:593-600
7. Ohgami T, Kitamoto T, Shin R-W, et al. Increased senile plaques without microglia in Alzheimer's disease. Acta Neuropathol 1991;81:242-47
8. Pike CJ, Cummings BJ, Cotman CW. Early association of reactive astrocytes with senile plaques in Alzheimer's disease. Exp Neurol 1995; 132:172-79
9. Fukumoto H, Asami-Odaka A, Suzuki N, et al. Association of AA40- positive senile plaques with microglial cells in the brains of patients with Alzheimer's disease and in non-demented aged individuals. Neurodegeneration 1996;5:13-17
10. Sheng JG, Mrak RE, Griffin WST. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms. Acta Neuropathol 1997; 94:1-5
11. Shah P, Lal N, Leung E, et al. Neuronal and axonal loss are selectively linked to fibrillar amyloid-A within plaques of the aged primate cerebral cortex. Am J Pathol 2010;177:325-33
12. Serrano-Pozo A, Frosch MP, Masliah E, et al. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med 2011;1: a006189
13. Knowles RB, Wyart C, Buldyrev SV, et al. Plaque-induced neurite abnormalities: Implications for disruption of neural networks in Alzheimer's disease. Proc Natl Acad Sci USA 1999;96:5274-79
14. D'Amore JD, Kajdasz ST, McLellan ME, et al. In vivo multiphoton imaging of a transgenic mouse model of Alzheimer disease reveals marked thioflavin-SYassociated alterations in neurite trajectories. J Neuropathol Exp Neurol 2003;62:137-45
15. Serrano-Pozo A, William CM, Ferrer I, et al. Beneficial effect of human antiYamyloid-A active immunization on neurite morphology and tau pathology. Brain 2010;133:1312-27
16. Koffie RM, Meyer-Luehmann M, Hashimoto T, et al. Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques. Proc Natl Acad Sci USA 2009; 106:4012-17
17. Koffie RM, Hashimoto T, Tai HC, et al. Apolipoprotein E4 effects in Alzheimer's disease are mediated by synaptotoxic oligomeric amyloid-A. Brain 2012;135:2155-68
18. Vehmas AK, Kawas CH, Stewart WF, et al. Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol Aging 2003;24:321-31
19. Kraft AW, Hu X, Yoon H, et al. Attenuating astrocyte activation accelerates plaque pathogenesis in APP/PS1 mice. FASEB J 2013;27:1-12
20. Wyss-Coray T. Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? Nat Med 2006;12:1005-15
21. Serrano-Pozo A, Mielke ML, Gómez-Isla T, et al. Reactive glia not only associates with plaques but also parallels tangles in Alzheimer disease. Am J Pathol 2011;179:1373-84
22. Serrano-Pozo A, Mielke ML, Muzitansky A, et al. Stable size distribution of amyloid plaques over the course of Alzheimer disease. J Neuropath Exp Neurol 2012;71:694-701
23. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44
24. The National Institute of Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol Aging 1997;18:S1-S2
25. Arnold SE, Hyman BT, Flory J, et al. The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb Cortex 1991; 1:103-16
26. Braak H, Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991;82:239-59
27. Beach TG, Walker R, McGeer EG. Patterns of gliosis in Alzheimer's disease and aging cerebrum. Glia 1989;2:420-36
28. Ito D, Imai Y, Ohsawa K, et al. Microglia-specific localization of a novel calcium binding protein, Iba1. Mol Brain Res 1998;57:1-9
29. Verbeek MM, Otte-Ho?ller I, Wesseling P, et al. A lysosomal marker for activated microglial cells involved in Alzheimer classic senile plaques. Acta Neuropathol 1995;90:493-503
30. Hyman BT, Gómez-Isla T, Irizarry MC. Stereology: A practical primer for neuropathology. J Neuropathol Exp Neurol 1998;57:305-10
31. Ingelsson M, Shin Y, Irizarry MC, et al. Genotyping of apolipoprotein E: Comparative evaluation of different protocols. Curr Protoc Hum Genet 2003;14:1-13
32. Hyman BT, Marzloff K, Arriagada PV. The lack of accumulation of senile plaques or amyloid burden in Alzheimer's disease suggests a dynamic balance between amyloid deposition and resolution. J Neuropathol Exp Neurol 1993;52:594-600
33. Hyman BT, West HL, Rebeck GW, et al. Quantitative analysis of senile plaques in Alzheimer disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc Natl Acad Sci USA 1995;92:3586-90
34. Datta S, Satten GA. Rank-sum tests for clustered data. J Am Stat Assoc 2005;100:908-15
35. Schmechel DE, Saunders AM, Strittmatter WJ, et al. Increased amyloid AYpeptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc Natl Acad Sci USA 1993;90:9649-53
36. Polvikoski T, Sulkava R, Haltia M, et al. Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein. N Engl J Med 1995;333: 1242-47
37. Gómez-Isla T, West HL, Rebeck GW, et al. Clinical and pathological correlates of apolipoprotein E ?4 in Alzheimer's disease. Ann Neurol 1996;39:62-70
38. McNamara MJ, Gómez-Isla T, Hyman BT. Apolipoprotein E genotype and deposits of AA40 and AA42 in Alzheimer disease. Arch Neurol 1998; 55:1001-4
39. Koistinaho M, Lin S, Wu X, et al. Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-beta peptides. Nat Med 2004;10:719-26
40. Terwell D, Steffensen KR, Verghese PB, et al. Critical role of astroglial apolipoprotein E and liver X receptor-> expression for microglial AA phagocytosis. J Neurosci 2011;31:7049-59
41. Jiang Q, Lee CY, Mandrekar S, et al. ApoE promotes the proteolytic degradation of AA. Neuron 2008;58:681-93
42. Zhao L, Lin S, Bales KR, et al. Macrophage-mediated degradation of A-amyloid via an apolipoprotein EYdependent mechanism. J Neurosci 2009;29:3603-12
43. Zhu Y, Nwabuisi-Heath E, Dumanis SB, et al. APOE genotype alters glial activation and loss of synaptic markers in mice. Glia 2012;60: 559-69
44. Cudaback E, Li X, Montine KS, et al. Apolipoprotein E isoformY dependent microglia migration. FASEB J 2011;25:2082-91
45. Ishikuza K, Kimura T, Igata-yi R, et al. Identification of monocyte chemoattractant protein-1 in senile plaques and reactive microglia of Alzheimer's disease. Psychiatry Clin Neurosci 1997;51:135-38
46. Stoltzner SE, Grenfell TJ, Mori C, et al. Temporal accrual of complement proteins in amyloid plaques in Down's syndrome with Alzheimer's disease. Am J Pathol 2000;156:489-99
47. Wyss-Coray T, Loike JD, Brionne TC, et al. Adult mouse astrocytes degrade amyloid-A in vitro and in situ. Nat Med 2003;9:453-57
48. Ryu JK, Cho T, Choi HB, et al. Microglial VEGF receptor response is an integral chemotactic component in Alzheimer's disease pathology. J Neurosci 2009;29:3-13
49. Davis JB, McMurray HF, Schubert D. The amyloid beta-protein of Alzheimer's disease is chemotactic for mononuclear phagocytes. Biochem Biophys Res Comm 1992;189:1096-100
50. Yan SD, Chen X, Fu J, et al. RAGE and amyloid-A peptide neurotoxicity in Alzheimer's disease. Nature 1996;382:685-91
51. El Khoury J, Hickman SE, Thomas CA, et al. Scavenger receptor-mediated adhesion of microglia to A-amyloid fibrils. Nature 1996;382:716-19
52. Le Y, Gong W, Tiffany HL, et al. Amyloid A42 activates a GproteinYcoupled chemoattractant receptor, FPR-like-1. J Neurosci 2001; 21:RC123(1-5)
53. Shankar GM, Li S, Mehta TH, et al. Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 2008;14:837-42
54. Hong S, Quintero-Monzon O, Ostaszewski BL, et al. Dynamic analysis of amyloid AYprotein in behaving mice reveals opposing changes in ISF versus parenchymal AA during age-related plaque formation. J Neurosci 2011;31:15861-69
55. Hickman SE, Allison EK, El Khoury J. Microglial dysfunction and defective A-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci 2008;28:8354-60
56. Bolmont T, Haiss F, Eicke D, et al. Dynamics of the microglial/amyloid interaction indicate a role in plaque maintenance. J Neurosci 2008;28: 4283-92
57. Grathwohl SA, Ka?lin RE, Bolmont T, et al. Formation and maintenance of Alzheimer's disease A-amyloid plaques in the absence of microglia. Nat Neurosci 2009;12:1358-60
58. Heneka MT, Nadrigny F, Regen T, et al. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc Natl Acad Sci USA 2010;107:6058-63
59. Liu Z, Condello C, Schain A, et al. CX3CR1 in microglia regulates brain amyloid deposition through selective protofibrillar amyloid-A phagocytosis. J Neurosci 2010;30:17091-101
60. Simard AR, Soulet D, Gowing G, et al. Bone marrowYderived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 2006;49:489-502
61. El Khoury J, Toft M, Hickman SE, et al. Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med 2007;13:432-38
62. Wu H, Hudry E, Hashimoto T, et al. Amyloid beta induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. J Neurosci 2010;30:2636-49
63. Ingelsson M, Fukumoto H, Newell KL, et al. Early AA accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 2004;62:925-31
64. Egensperger R, Ko?sel S, von Eitzen U, et al. Microglial activation in Alzheimer disease: Association with APOE genotype. Brain Pathol 1998;8:439-47